ANTI-PD-L1 IMMUNOTOXIN FOR USE IN THERAPY
- 专利权人:
- 发明人:
- 申请号：
- EP16716519.0
- 公开号：
- EP3280439A1
- 申请日:
- 2016.04.06
- 申请国别(地区):
- EP
- 年份:
- 2018
- 代理人:
- 摘要：
- The present disclosure relates to a combination of an anti-PD-L1 (Programmed Cell Death 1 Ligand 1) with an ‘immunotoxin’ for use in a method for treating a tumor in a patient. Experimental results are provided for a combination of an anti POL 1 antibody with the radioisotope Indium 111.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- ANTI-PD-L1 IMMUNOTOXIN FOR USE IN THERAPY
- ANTI-PD-L1 IMMUNOTOXIN FOR USE IN THERAPY
- GENE EXPRESSION SIGNATURE AS A PREDICTOR OF CHEMOTHERAPEUTIC RESPONSE IN BREAST CANCER
- SYSTEMS DEVICES AND METHODS FOR ANTI TL1A THERAPY
- Breast cancer prognosis, prediction of response to anti-progestin treatment based on the prediction and gene expression of progesterone receptor subtypes
